FIELD: parapharmaceuticals.
SUBSTANCE: invention relates to an agent for relieving or reducing hangover syndrome. Composition of the agent contains in wt.%: vitamin B1—0.298–0.400, vitamin B2—0.358–0.480, vitamin B3—3.578–5.329, vitamin B6—0.358–0.533, succinic or fumaric acid—29.815–53.291, alpha-lipoic acid or ubiquinone—5.963–13.323, dimethylaminoethanol (DMAE) or L-DMAE bitartrate—the rest. Alternatively, the composition of the agent contains a mixture of at least two compositions in effective amounts selected from the above composition and one or more compositions selected from the following compositions. Composition contains the following in wt.%: glycine—5.882–46.875, taurine—18.750–29.412, L-tryptophan or 5-hydroxytrypthan—5.882–18.750 and arginine alpha-ketoglutarate or L-arginine—the rest; composition containing in wt.%: citrulline DL-malate or L-citrulline—1.851–7.831, N-acetylcysteine—1.851–9.789, L-lysine or L-lysine hydrochloride—7.831–18.513, L-glutamine—7.831–18.513, L-tyrosine—7.831–22.216, L-cysteine—7.405–9.789, sodium citrate or sodium chloride—9.789–11.108, potassium citrate or potassium chloride, or potassium orotate, or potassium citrate, or potassium asparaginate—7.405–19.577, selenomethionine or selenium—0.030–0.157, magnesium citrate, or magnesium oxide, or magnesium glycinate, or magnesium malate, or magnesium taurate, or magnesium orotate, or magnesium carbonate, or magnesium lactate, or magnesium sulphate, or magnesium asparaginate—the rest, or a composition containing in wt.%: vitamin B8 or myo-inositol—3.858–33.932, vitamin B9—0.006–0.014, piperine or biopiperine—0.096%—0.452%, L-carnitine or L-carnitine tartrate—1.929%—20.359%, betaine hydrochloride or trimethylglycine citrate—the rest.
EFFECT: invention widens the range of compositions for relieving or reducing hangover syndrome, as well as obtaining an effective composition which promotes elimination of negative symptoms of hangover and their causes.
4 cl, 1 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING GENERAL TONIC, ADAPTOGENIC AND IMMUNITY DECREASE PREVENTING ACTION, AND METHOD FOR PREPARING IT | 2011 |
|
RU2484842C2 |
SPECIALIZED FOOD PRODUCT INTENDED FOR NUTRITION OF PATIENTS DURING THE PERIOD OF TREATMENT OF NON-ALCOHOLIC FAT LIVER DISEASE | 2021 |
|
RU2761163C1 |
AGENT POSSESSING ADAPTOGENIC, TONIC AND GENERAL TONIC ACTION, AND METHOD FOR PREPARING IT | 2011 |
|
RU2468812C2 |
BIOLOGICALLY ACTIVE SUBSTANCES COMPOSITION WITH GEROPROTECTIVE ACTIVITY AND METHOD FOR COMPLEX CORRECTION OF AGE-RELATED CHANGES OF HORMONAL BALANCE, EPIPHYSIS FUNCTIONS AND ANTIOXIDANT STATUS INVOLVING SAID COMPOSITION ADMINISTRATION | 2011 |
|
RU2464816C1 |
FOOD VITAMIN-MINERAL SUPPLEMENT | 2007 |
|
RU2335926C1 |
GRAIN BAR CONTAINING AMINO-ACID VITAMIN-AND-MINERAL COMPLEX AND BAR PRODUCTION METHOD | 2010 |
|
RU2468606C2 |
HEPATOPROTECTIVE AND ANTIHEPATOTOXIC PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING HEPATIC DISEASES THAT INVOLVES INTRODUCTION OF SAID COMPOSITION | 2008 |
|
RU2381800C1 |
AGENT ELICITING HEPATOPROTECTIVE AND ANTI-ENCEPHALOPATHIC PROPERTY FOR REDUCING ALCOHOLIC INTOXICATION, PROPHYLAXIS AND REMOVING ALCOHOLIC INTOXICATION AND WITHDRAWAL SYNDROME | 2004 |
|
RU2254858C1 |
COMPOSITION POSSESSING ANALGESIC, ANTI-INFLAMMATORY AND LOCOMOTOR FUNCTION IMPROVING ACTION | 2011 |
|
RU2468805C2 |
METHOD FOR TREATMENT OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE USING SPECIALIZED FOOD PRODUCT | 2021 |
|
RU2761164C1 |
Authors
Dates
2024-07-22—Published
2023-09-01—Filed